Literature DB >> 8435687

How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Old Age Depression Interest Group.

.   

Abstract

Of 219 elderly patients with a major depressive disorder (meeting RDC), 69 recovered sufficiently and consented to enter a two-year double-blind placebo-controlled trial of dothiepin. Survival analysis revealed that dothiepin reduced the relative risk of relapse by two and a half times. Past but not current serious physical illness was also associated with a favourable outcome, whereas a prolonged index depressive illness trebled the relative risk of relapse. In the light of previous research on prognosis it is suggested that elderly persons who recover from a major depressive illness should continue with antidepressant medication for at least two years, if not indefinitely.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435687

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  24 in total

Review 1.  Care of older people: Mental health problems.

Authors:  A Burns; T Dening; R Baldwin
Journal:  BMJ       Date:  2001-03-31

Review 2.  Antidepressants in the elderly: challenges for study design and their interpretation.

Authors:  C Parikh
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 3.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 5.  Psychotropic drugs, aging and community care.

Authors:  M Philpot; A Puranik
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 6.  Minor depression in the aged. Concepts, prevalence and optimal management.

Authors:  C Tannock; C Katona
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

Review 7.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 8.  Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age.

Authors:  Henry C Driscoll; Jordan F Karp; Mary Amanda Dew; Charles F Reynolds
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 9.  Depression in adults: drug and physical treatments.

Authors:  Corrado Barbui; Rob Butler; Andrea Cipriani; John Geddes; Simon Hatcher
Journal:  BMJ Clin Evid       Date:  2007-06-15

Review 10.  Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.

Authors:  A J Flint
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.